Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2022, Recode Ventures is a U.S.-based venture capital firm that focuses on early-stage healthcare companies. The firm primarily invests at the seed and Series A stages, with a portfolio currently comprising 7 companies. Recode Ventures emphasizes technology integration to address significant global health challenges.
Recode Ventures invests in companies that operate at the intersection of healthcare and technology, particularly in sectors like machine learning, nanotechnology, robotics, and augmented reality. Their investment thesis targets early-stage companies that leverage deep tech to transform healthcare delivery and outcomes.
Notable portfolio companies include Caption Care, which focuses on heart disease detection; Probably Genetic, aimed at expediting rare condition diagnoses; Lab Genius, which accelerates advanced medicine discovery; Waypoint Bio, utilizing AI/ML for cancer therapies; Proprio, enhancing surgical planning with AR/VR; Nanograb, targeting genetic drugs using computational biology; and Sensible Biotechnologies, developing mRNA therapeutics.
Submit through their form at https://www.recodeventures.com/contact.
Yes, Recode Ventures often leads investment rounds, particularly in seed and Series A stages.
The firm is open to follow-on investments, especially if the portfolio company demonstrates significant growth and potential.
Specific fund size details are not disclosed, but the firm focuses on early-stage investments in healthcare technology.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.